Naoya Sugimoto
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
One-year clinical remission with tezepelumab in severe asthma: TERESA single-arm prospective study.
Journal: The Journal of allergy and clinical immunology
Published: December 16, 2025
Differential responses of group 2 innate lymphoid cells and TH2 cells to benralizumab in severe asthma.
Journal: The Journal of allergy and clinical immunology
Published: October 26, 2025
Risk Factors for COVID-19 mRNA Vaccine-Associated Exacerbations in Patients With Obstructive Airway Diseases: REsearch for Asthma and COPD ExacerbaTION Caused by COVID-19 mRNA Vaccination (REACTION Study).
Journal: Allergy, asthma & immunology research
Published: August 28, 2025
Corrigendum to "Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial" [Allergol Int 74 (2025) 274-82].
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: June 14, 2025
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy.
Journal: Breast cancer (Tokyo, Japan)
Published: November 07, 2024
Clinical remission of mild-to-moderate asthma: Rates, contributing factors, and stability.
Journal: The journal of allergy and clinical immunology. Global
Published: August 13, 2024
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case-control study of abemaciclib-induced interstitial lung disease (NOSIDE).
Journal: Breast cancer (Tokyo, Japan)
Published: July 04, 2024
Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: June 10, 2024
Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q).
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: September 07, 2022
THE OVERLAPPING ELIGIBILITY FOR BIOLOGICS IN PATIENTS WITH SEVERE ASTHMA AND PHENOTYPES
Journal: Arerugi = [Allergy]
Published: May 15, 2022
The prevalence of comorbid respiratory disease among COVID-19 patients, and mortality during the first wave in Japan: A nationwide survey by the Japanese Respiratory Society.
Journal: Respiratory investigation
Published: April 15, 2021
Mepolizumab decreased the levels of serum galectin-10 and eosinophil cationic protein in asthma.
Journal: Asia Pacific allergy
Published: January 31, 2021
Last Updated: 09/26/2026